GPR31 (C-Term) Polyclonal Antibody
|
|
- $315 - $347
- Product name: GPR31 (C-Term) Polyclonal Antibody
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:GPR31 (C-Term) Polyclonal Antibody
2 prices
Selected condition:
Brand
- Cayman Chemical
Package
- 1ea
- ManufacturerCayman Chemical
- Product number14083
- Product descriptionGPR31 (C-Term) Polyclonal Antibody
- Packaging1ea
- Price$347
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number14083
- Product descriptionGPR31 (C-Term) Polyclonal Antibody
- Packaging1ea
- Price$315
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Cayman Chemical | 14083 | GPR31 (C-Term) Polyclonal Antibody | 1ea | $347 | 2026-04-30 | Buy |
| Cayman Chemical | 14083 | GPR31 (C-Term) Polyclonal Antibody | 1ea | $315 | 2024-03-01 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
GPR31 is a 319 amino acid G protein-coupled receptor (GPCR) that acts as the receptor for the arachidonic acid metabolite 12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(S)-HETE) (Item No. 34570). Binding of 12(S)-HETE to GPR31 leads to the activation of ERK1/2 (MAPK3/MAPK1), MEK, and NF-κB pathways. The dysregulation of GPR31 has been implicated in diseases such as arthritis, Alzheimer’s disease, and prostate cancer.1WARNING This product is not for human or veterinary use.More related product prices
Related product price
-
GPR31 (N-Term) Polyclonal Antibody
$340-374 -
Nrf2 (C-Term) Polyclonal Antibody
$315-347 -
FFAR4 (GPR120) (C-Term) Polyclonal Antibody
$315-347




